Transfusion associated graft versus host disease
Gupta, A.; Bansal, D.; Dass, R.; Das, A.
Indian Pediatrics 41(12): 1260-1264
2004
ISSN/ISBN: 0019-6061 PMID: 15623910 Document Number: 570934
Transfusion-associated graft-versus-host disease (TA-GVHD) is a dreaded complication in immunocompromized hosts. The diagnosis is often delayed because of lack of awareness and the non-specific clinical features. More than 90% patients succumb to refractory infections. The only effective preventive measure is administration of irradiated blood products, which must be made available in centers managing immunocompromised patients. We report three cases and discuss pathophysiology and preventive strategies in this communication.
Document emailed within 1 workday
Related Documents
Bojanić, I.; Cepulić, B.G.ć 2004: Transfusion-associated graft-versus-host disease Lijecnicki Vjesnik 126(1-2): 39-47Gössi, U.; Bucher, U.; Brun del Re, G.; Miloni, E.; Hess, T. 1985: Acute graft-versus-host disease following a single transfusion of erythrocytes Schweizerische Medizinische Wochenschrift 115(2): 34-40
Sebnem Kilic, S.; Kavurt, S.; Balaban Adim, S. 2010: Transfusion-associated graft-versus-host disease in severe combined immunodeficiency Journal of Investigational Allergology and Clinical Immunology 20(2): 153-156
Otori, K.; Masuda, C.; Wanibuchi, H.; Nakanishi, A.; Kawabata, K.; Ohashi, H.; Fukushima, S. 1999: An autopsy report of graft-versus-host disease (GVHD) following blood transfusion Osaka City Medical Journal 45(1): 37-43
Hovdenes, J.; Solheim, B.G. 1995: Transfusion-associated graft-versus-host disease. Increased risk when using HLA matched donors Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(12): 1499-1501
Tanaka, S. 1997: Prevention of post-transfusion graft versus host disease by irradiating blood products with X-ray or gamma-ray Nihon Rinsho. Japanese Journal of Clinical Medicine 55(9): 2277-2281
de Gast, G.C.; Beatty, P.G.; Amos, D.; Sullivan, K.; Anderson, J.E.; Thomas, E.D.; Hansen, J.A. 1987: Transfusion effect on graft-versus-host disease and leukemic relapse in HLA-matched bone marrow transplantation Transplantation Proceedings 19(1 Pt 3): 2700
Park, B.H.; Good, R.A.; Gate, J.; Burke, B. 1974: Fatal graft-vs.-host reaction following transfusion of allogeneic blood and plasma in infants with combined immunodeficiency disease Transplantation Proceedings 6(4): 385-387
Ushiyama, C.; Hirano, T.; Miyajima, H.; Okumura, K.; Ovary, Z.; Hashimoto, H. 1995: Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease Journal of Immunology 154(6): 2687-2696
Atkinson, K.; Downs, K. 1995: Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation Bone Marrow Transplantation 16(6): 755-758
Via, C.S.; Rus, V.; Gately, M.K.; Finkelman, F.D. 1994: IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease Journal of Immunology 153(9): 4040-4047
Nishimura, M.; Hidaka, N.; Akaza, T.; Tadokoro, K.; Juji, T. 1998: Differential effect of azidothymidine on resting and activated cells: potentiality of this drug for treatment of post-transfusion graft-versus-host disease Research Communications in Molecular Pathology and Pharmacology 100(2): 131-138
Atkinson, K.; Storb, R.; Weiden, P.L.; Deeg, H.J.; Gerhard-Miller, L.; Thomas, E.D. 1980: In vitro tests correlating with presence or absence of graft-vs-host disease in DLA nonidentical canine radiation chimeras: evidence that clonal abortion maintains stable graft-host tolerance Journal of Immunology 124(4): 1808-1814
Li, V.; Molina, L.; Michallet, M.; Hostein, J. 1992: Digestive manifestations of graft-versus-host disease (GVHD) in bone marrow transplantation, organ transplantation and transfusion Gastroenterologie Clinique et Biologique 16(1): 29-36
Frezza, E.E.; Gerunda, G.E.; Fassina, A.; DeFranchis, R.; Biffi, R.; Gurakar, A.; Fagiuoli, S.; Maffei, F.A.; Van Thiel, D.H. 1994: NK activity during graft-vs-host disease and graft rejection in rats following intestinal transplantation Transplantation Proceedings 26(3): 1626
Jansen, J.; Goselink, H.M.; Veenhof, W.F.; Zwaan, F.E.; Blotkamp, C. 1983: The impact of the composition of the bone marrow graft on engraftment and graft-versus-host disease Experimental Hematology 11(10): 967-973
Dey, B.; Yang, Y.G.; Preffer, F.; Shimizu, A.; Swenson, K.; Dombkowski, D.; Sykes, M. 1999: The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model Transplantation 68(1): 141-149
You-Ten, K.E.; Lapp, W.S. 1996: The role of endogenous glucocorticoids on host T cell populations in the peripheral lymphoid organs of mice with graft-versus-host disease Transplantation 61(1): 76-83
Haanen, C.; De Witte, T.; Plas, A.; Schattemberg, T. 1991: Prevention of graft-versus-host disease by lymphocyte depletion of the bone marrow graft with use of counterflow centrifugation Haematologica 76 Suppl. 1: 22-28
Liem, L.M.; van Noort, J.T.; Goulmy, E. 1996: Anti-host cytotoxic T cells of bone marrow transplant recipients with or without graft-versus-host disease are equally sensitive to cyclosporin a Bone Marrow Transplantation 18(1): 73-78